Value proposition
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.
For more information, visit ipsen.com.
Pauta exclusiva para México:
Clave de Autorización COFEPRIS: 243300201B1962
CONSULTE A SU MÉDICO.
Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, and Primary CareOriginal language
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.
For more information, visit ipsen.com.
Pauta exclusiva para México:
Clave de Autorización COFEPRIS: 243300201B1962
CONSULTE A SU MÉDICO.
Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care
Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care
https://www.ipsen.com/
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Wakam Insurance, insurtech | Not capitalistic Partnership Event 13 Jun 2018 | | |
 | ERELIA IT Services and IT Consulting, it services, industry 4.0 | Not capitalistic Not partnership Event 10 Feb 2018 | | |
 | Fondation La Vie au Grand Air I Priorité Enfance Civic and Social Organizations, edtech | Other 2 Dec 2021 12 Dec 2024 | | |
 | Queen's University Belfast Higher Education, healthtech | Other 23 Nov 2021 | | |
 | Fondation Saint-Hélier Hospitals and Health Care, healthtech | Other 13 Jan 2022 | | |
 | BioLabs Biotechnology Research | Other 1 Apr 2020 2 May 2024 | | |
 | Aitia Biotechnology Research, biotech, deeptech | Not capitalistic Not partnership Event 22 Apr 2022 | | |
 | L'AGEFI | Other 27 May 2020 | | |
 | Outwrite PR Public Relations and Communications Services | Other 20 Nov 2015 | | |
 | CHEManager International Newspaper Publishing | Other 28 Feb 2022 | | |